CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private Healthcare System
Abstract
Authors
M. Falavigna S.F. Watanabe J. Santoro K. Ribeiro N. Schneider M. Safadi R.T. Stein A. Kieffer A. Tolardo